virus
develop
sudv
infect
hors
antisudv
purifi
immunoglobulin
lay
foundat
sudv
therapeut
drug
research
abstract
ebola
viru
infect
lead
sever
hemorrhag
fever
human
nonhuman
primat
human
fatal
rate
high
sinc
ebola
viru
discov
avail
treatment
medic
support
emerg
administr
experiment
drug
absenc
licens
vaccin
drug
ebola
viru
imped
prevent
viral
infect
studi
gener
recombin
baculovirus
rbv
express
sudan
viru
sudv
matrix
structur
protein
sudv
glycoprotein
gp
rbvgpgp
sudv
viruslik
particl
vlp
produc
coinfect
cell
rbvsudvgp
express
sudv
gp
sudv
vlp
demonstr
ifa
western
blot
analysi
electron
microscopi
result
demonstr
sudv
vlp
filament
morpholog
immunogen
sudv
vlp
produc
insect
cell
evalu
immun
mice
analysi
antibodi
respons
show
mice
vaccin
sudv
vlp
adjuv
montanid
isa
produc
sudv
gpspecif
igg
antibodi
sera
sudv
vlpimmun
mice
abl
block
infect
sudv
gp
pseudotyp
hiv
indic
neutral
antibodi
sudv
gp
protein
produc
furthermor
activ
b
cell
group
immun
vlp
mix
montanid
isa
signific
one
week
primari
immun
vaccin
sudv
vlp
markedli
increas
frequenc
antigenspecif
cell
secret
type
type
cytokin
studi
therapeut
effect
sudv
antibodi
hors
immun
sudv
vlp
emulsifi
freund
complet
adjuv
freund
incomplet
adjuv
result
show
hors
could
produc
sudv
gpspecif
antibodi
neutral
antibodi
result
show
sudv
vlp
demonstr
excel
immunogen
repres
promis
approach
vaccin
human
furthermor
preexist
immun
associ
live
carrier
vaccin
hinder
vlpbase
immun
previou
find
show
sudv
vlp
could
readili
assembl
coexpress
insect
cell
baculovirus
express
gp
np
current
approv
special
drug
vaccin
protect
sudv
diseas
outbreak
thu
urgent
need
develop
efficaci
safe
econom
viabl
vaccin
therapeut
antibodi
control
sudv
infect
report
product
sudv
vlp
accomplish
insect
cell
coinfect
recombin
baculovirus
rbvgpgp
evalu
abil
sudvvlp
induc
sudvspecif
humor
cellular
immun
respons
vaccin
mice
hors
immun
sudv
vlp
hors
serum
purifi
prepar
purifi
immunoglobulin
purifi
immunoglobulin
neutral
activ
cell
atcc
cultur
dulbecco
modifi
eagl
medium
dmem
corningcostar
core
ny
usa
supplement
fetal
bovin
serum
penicillinstreptomycin
fb
gibco
grand
island
ny
usa
cell
maintain
c
spodoptera
frugiperda
cell
invitrogen
san
diego
ca
usa
cultur
suspens
ii
serumfre
medium
invitrogen
san
diego
ca
usa
supplement
fb
penicillinstreptomycin
cell
maintain
c
femal
balbc
mice
week
old
purchas
changchun
institut
biolog
product
changchun
china
experi
involv
mice
adher
principl
welfar
ethic
committe
militari
veterinari
research
institut
academi
militari
scienc
mice
provid
ad
libitum
access
steril
water
food
throughout
studi
vaccin
condit
healthi
male
hors
year
old
kg
provid
red
hill
militari
hors
farm
changchun
china
hors
studi
conduct
prior
approv
anim
welfar
ethic
committe
institut
militari
veterinari
academi
militari
medic
scienc
permit
number
accord
hors
quarantin
immun
protocol
equin
serum
product
clone
construct
recombin
bacmid
pfastbacdualgpgp
carri
briefli
synthes
fulllength
gp
figur
recombin
plasmid
supplementari
figur
construct
use
strategi
recombin
plasmid
use
transform
e
coli
compet
cell
gener
recombin
bacmid
cell
transfect
recombin
bacmid
use
cellfectin
ii
reagent
thermo
scientif
carlsbad
ca
usa
accord
manufactur
instruct
transfect
cell
incub
c
harvest
recombin
baculovirus
rbvgpgp
collect
cell
supernat
sudv
gp
aa
protein
gener
prokaryot
express
system
briefli
synthes
gene
encod
sudv
gp
aa
protein
separ
insert
prokaryot
express
vector
pet
use
bamhi
noti
infram
cand
nterminu
construct
pet
gphiscn
pet
recombin
plasmid
confirm
restrict
digest
two
recombin
plasmid
transform
e
coli
transgen
biotech
beij
china
transform
select
luriabertani
lb
agar
plate
kanamycin
singl
clone
pick
inocul
ml
lb
medium
kanamycin
c
overnight
growth
express
induc
addit
mm
iptg
optic
densiti
nm
od
reach
protein
purifi
use
hispurtm
ninta
spin
purif
kit
thermo
scientif
carlsbad
ca
usa
accord
manufactur
instruct
visual
express
purifi
protein
sampl
resolv
sdspolyacrylamid
gel
sdspage
stain
coomassi
blue
protein
concentr
determin
use
bicinchonin
acid
bca
assay
thermo
scientif
carlsbad
ca
usa
follow
analysi
absorb
nm
bovin
serum
albumin
bsa
sigmaaldrich
st
loui
mo
usa
use
protein
standard
polyclon
antisera
sudv
gp
aa
prepar
immun
balbc
mice
purifi
gp
recombin
protein
twice
interv
harvest
mous
serum
mous
polyclon
antisera
sudv
gp
aa
cell
infect
fourth
gener
recombin
baculoviru
rbacgpgp
approxim
h
infect
cell
fix
paraformaldehyd
min
room
temperatur
cell
wash
pb
block
pb
contain
bsa
sigmaaldrich
st
loui
mo
usa
cell
incub
dilut
mous
polyclon
antisera
sudv
gp
mous
polyclon
antisera
sudv
gener
lab
h
c
wash
pb
incub
fitcconjug
goat
antimous
igg
bioss
antibodi
beij
china
contain
dilut
evan
blue
h
c
infect
cell
wash
pbst
contain
three
time
observ
fluoresc
microscop
control
cell
incub
two
primari
antisera
time
baculoviru
titer
determin
use
bacpaktm
baculoviru
rapid
titer
kit
takara
dalian
china
gener
sudv
vlp
cell
coinfect
recombin
baculovirus
rbvgpgp
differ
ratio
sudv
vlp
harvest
postinfect
purifi
vlp
cultur
supernat
harvest
spun
g
crude
vlp
concentr
ultracentrifug
g
h
pellet
resuspend
pb
purif
discontinu
sucros
gradient
band
sucros
collect
resuspend
endotoxinfre
pb
vlp
concentr
determin
use
bca
assay
thermo
scientif
carlsbad
ca
usa
follow
analysi
absorb
nm
vlp
prepar
test
endotoxin
product
purifi
sudv
vlp
process
examin
western
blot
transmiss
electron
microscopi
western
blot
aliquot
contain
total
protein
dilut
reduc
buffer
denatur
heat
c
min
protein
separ
acrylamid
gel
transfer
onto
polyvinyliden
fluorid
pvdf
membran
merck
millipor
darmstadt
germani
denatur
condit
protein
detect
two
polyclon
antisera
use
mous
antisudv
gp
polyclon
antisera
mous
antisudv
polyclon
antisera
mix
dilut
primari
antibodi
blot
goat
antimous
igg
hrpconjug
antibodi
bioss
antibodi
beij
china
use
dilut
secondari
antibodi
neg
stain
transmiss
electron
microscopi
tem
use
analyz
shape
size
purifi
sudv
vlp
short
sucros
gradientpurifi
sudv
vlp
fix
min
carbonco
formvar
grid
grid
wash
pb
treat
phosphotungst
acid
min
grid
left
air
dri
observ
use
hitachi
transmiss
electron
microscop
total
two
batch
balbc
mice
week
old
femal
purchas
changchun
yisi
laboratori
anim
technolog
co
ltd
changchun
china
immun
batch
one
mice
random
four
group
n
per
group
vaccin
intramuscularli
mice
group
one
vaccin
pb
mice
group
two
vaccin
montanid
isa
vg
isa
adjuv
seppic
pari
franc
mice
group
three
vaccin
sudv
vlpsonli
mice
group
four
vaccin
sudv
vlp
mix
equal
volum
montanid
isa
vg
isa
adjuv
group
vaccin
twice
interv
figur
mous
sera
collect
twoweek
everi
immun
one
week
booster
immun
splenocyt
mice
group
isol
batch
two
nine
mice
randomli
distribut
three
group
n
per
group
pb
group
isa
adjuv
sudv
vlp
mix
equal
volum
isa
adjuv
vaccin
intramuscularli
one
week
primari
immun
inguin
lymph
node
collect
mice
two
healthi
male
hors
number
year
old
kg
weight
without
detect
antibodi
sudv
detect
indirect
elisa
suppli
red
hill
militari
hors
farm
hors
multipoint
inject
subcutan
rear
area
mg
purifi
sudvvlp
total
time
primari
immun
mix
equal
volum
freund
incomplet
adjuv
thermo
scientif
rockford
il
usa
booster
immun
mix
equal
volum
freund
complet
adjuv
maximum
immun
volum
exceed
ml
boost
two
week
interv
figur
hors
sera
collect
immun
store
c
studi
mice
hors
serum
sampl
collect
two
week
immun
level
sudv
gpspecif
antibodi
detect
indirect
elisa
briefli
purifi
prokaryot
express
sudv
gp
coat
elisa
plate
concentr
overnight
c
plate
block
bsa
h
c
serum
ad
serial
dilut
bsa
plate
subsequ
incub
h
c
hrplabel
goat
antimous
igg
hrplabel
goat
antihors
igg
bioss
antibodi
beij
china
dilut
bsa
ad
well
one
hour
incub
c
tetramethylbenzidin
tmb
sigmaaldrich
st
loui
mo
usa
substrat
solut
ad
well
stop
addit
h
optic
densiti
od
valu
measur
wavelength
nm
od
incub
step
elisa
plate
wash
five
time
pbst
mean
od
valu
consid
posit
od
valu
two
time
valu
neg
control
pseudotyp
viru
neutral
assay
perform
test
neutralz
antibodi
recombin
lentivir
vector
express
sudv
glycoprotein
carri
luciferas
report
gene
produc
describ
previous
modif
briefli
cell
seed
cultur
dish
corn
ny
usa
h
later
subconflu
cell
cotransfect
pcdna
glycoprotein
express
vector
vector
lipofectamin
tm
transfect
reagent
thermo
scientif
carlsbad
ca
usa
day
supernat
contain
pseudotyp
virus
harvest
titer
determin
cell
previous
describ
test
neutral
antibodi
serial
dilut
serum
sampl
mix
tcid
pseudotyp
virus
h
c
ad
cell
h
inoculum
remov
replac
fresh
media
cell
lyse
h
cell
lysi
buffer
follow
addit
luciferas
substrat
promega
madison
wi
usa
determin
luciferas
activ
luciferas
activ
sampl
measur
infinit
micropl
spectrophotomet
tecan
mannedorf
switzerland
percent
inhibit
rate
calcul
previou
show
experi
independ
repeat
three
time
one
week
booster
immun
batch
one
three
mice
group
randomli
select
euthan
spleen
harvest
tissu
cultur
dish
spleen
roughli
minc
press
syring
cell
filter
filter
bd
falcon
strainer
centrifug
rpm
min
room
temperatur
cell
process
resuspens
red
blood
cell
lysi
buffer
centrifug
rpm
min
twice
room
temperatur
splenocyt
harvest
wash
rpmi
medium
gibco
san
diego
ca
usa
contain
fb
gibco
san
diego
ca
usa
splenocyt
cultur
rpmi
medium
contain
fb
stimul
without
purifi
sudvgp
antigen
follow
incub
c
co
h
frequenc
splenocyt
produc
measur
use
mous
elispot
kit
mabtech
ab
stockholm
sweden
accord
manufactur
instruct
spotform
cell
sfc
enumer
autom
elispot
reader
aid
elispot
readerispot
germani
level
cytokin
supernat
stimul
splenocyt
detect
commerci
elisa
splenocyt
stimul
describ
incub
h
cell
cultur
supernat
collect
centrifug
rpm
min
manufactur
direct
follow
detect
elisa
kit
mabtech
ab
stockholm
sweden
inguin
lymph
node
sampl
harvest
batch
two
vaccin
mice
day
primari
immun
lymphoid
cell
harvest
tissu
cultur
dish
roughli
minc
press
ml
syring
cell
filter
filter
bd
falcon
strainer
prepar
pb
fb
stain
equal
volum
dilut
antibodi
bd
bioscienc
franklin
va
usa
min
c
label
b
cell
wash
twice
pb
fb
analyz
use
facsaria
tm
cell
sorter
bd
bioscienc
franklin
va
usa
equin
antisera
blood
taken
jugular
vein
immun
hors
sera
collect
hors
serum
dilut
pb
ad
satur
ammonium
sulfat
solut
ammonium
sulfat
concentr
solut
allow
stand
c
h
centrifug
rpm
min
remov
supernat
precipit
dissolv
pb
satur
ammonium
sulfat
ad
concentr
ammonium
sulfat
solut
allow
stand
c
h
centrifug
rpm
min
precipit
dissolv
pb
dialyz
pb
c
h
remov
ammonium
salt
treatment
mice
accord
welfar
ethic
guidanc
laboratori
anim
china
gb
agreement
approv
anim
welfar
ethic
committe
institut
veterinari
medicin
militari
academi
scienc
laboratori
anim
care
use
committe
author
permit
number
sequenc
encod
gp
aa
protein
sudv
clone
prokaryot
express
vector
pet
result
plasmid
pet
gphiscn
pet
c
n
termin
correct
insert
sequenc
recombin
plasmid
confirm
restrict
digest
map
analysi
dna
sequenc
recombin
plasmid
pet
gphiscn
pet
transform
e
coli
cell
recombin
protein
sudv
gp
experess
cell
ad
mm
iptg
protein
purifi
affin
chromatographi
detect
sdspage
analysi
figur
purpos
express
sudv
gp
protein
prepar
antigp
polyclon
antisera
polyclon
antisera
two
polyclon
antisera
success
made
immun
mice
two
protein
twice
respect
identifi
success
rescu
recombin
baculoviru
effect
express
sudv
gp
protein
fourth
gener
recombin
baculoviru
detect
ifa
cell
infect
recombin
baculoviru
rbacgpgp
incub
mous
antigp
polyclon
polyclon
antisera
respect
incub
fitcconjug
goat
antimous
igg
immunofluoresc
result
show
cell
infect
recombin
baculoviru
rbacgpgp
shown
specif
green
figur
e
noninfect
cell
figur
show
mean
sudv
gp
protein
success
express
infect
cell
sudv
vlp
gener
coinfect
recombin
baculovirus
rbvgpgp
cell
sudv
vlp
harvest
cultur
supernat
purifi
describ
materi
method
character
structur
sudv
vlp
examin
purifi
materi
transmiss
electron
microscopi
neg
stain
studi
reveal
sudv
vlp
found
mimic
naiv
viru
structur
size
approxim
nm
diamet
nm
length
figur
ident
protein
compon
purifi
sudv
vlp
assess
western
blot
analysi
mous
antisudv
gp
polyclon
antisera
mous
antisudv
polyclon
antisera
gp
protein
present
vlp
figur
result
demonstr
sudv
gp
effici
assembl
sudv
vlp
releas
insect
cell
detect
sudvvlpinduc
humor
immun
respons
vaccin
balbc
mice
indirect
elisa
viru
neutral
assay
perform
evalu
product
sudv
gpspecif
antibodi
neutral
antibodi
fifth
week
immun
sera
mice
treat
sudv
vlp
mix
isa
adjuv
group
high
titer
sudv
specif
igg
antibodi
endpoint
titer
figur
virusneutr
antibodi
titer
averag
individu
mice
neutral
antibodi
titer
figur
show
signific
diverg
compar
pb
group
isa
adjuv
group
sudv
specif
igg
antibodi
neutral
antibodi
detect
vlpsonli
group
mice
result
demonstr
sudv
vlp
antigen
dose
stimul
product
antibodi
mice
antigen
dose
mix
adjuv
stimul
mice
produc
specif
igg
antibodi
neutral
antibodi
hors
b
analysi
sudvvlpinduc
specif
igg
antibodi
respons
indirect
elisa
two
week
everi
immun
vaccin
mice
c
sudv
neutral
antibodi
titer
detect
immun
mice
two
week
booster
immun
limit
detect
lod
mean
minimum
concentr
content
detect
determin
experiment
condit
error
bar
repres
standard
deviat
pvalu
determin
accord
tukey
multipl
comparison
test
p
p
elispot
assay
use
evalu
antigenspecif
cellular
immun
respons
vaccin
mice
sinc
vlpsonli
stimul
product
specif
antibodi
neutral
antibodi
vlpsonli
group
remov
cellular
immun
respons
experi
result
elispot
assay
shown
figur
sfc
produc
splenocyt
mice
immun
sudv
vlp
mix
isa
adjuv
significantli
higher
compar
mice
immun
pb
isa
immun
sudv
vlp
mix
isa
adjuv
also
result
increas
respons
sfc
product
significantli
higher
follow
immun
pb
isa
figur
result
demonstr
sudv
vlp
mix
isa
adjuv
enhanc
respons
mice
statist
analysi
two
group
analyz
use
tukey
multipl
comparison
test
p
p
investig
antigenspecif
cellular
immun
respons
induc
sudv
vlp
cytokin
secret
splenocyt
measur
commerci
elisa
kit
splenocyt
harvest
mice
one
week
booster
immun
stimul
prokaryoticexpress
sudv
gp
aa
cytokin
secret
supernat
splenocyt
assess
type
cytokin
figur
figur
figur
significantli
higher
group
immun
sudv
vlp
mix
isa
adjuv
pb
isa
adjuv
group
type
cytokin
figur
figur
show
trend
result
indic
sudv
vlp
mix
isa
adjuv
potent
enhanc
cellular
immun
respons
mice
humor
immun
respons
hors
assess
week
immun
figur
serum
sampl
collect
measur
sudv
gpspecif
antibodi
neutral
antibodi
level
sudv
gpspecif
igg
antibodi
detect
second
week
figur
fifth
immun
titer
sudv
gpspecif
igg
antibodi
hors
hors
result
reveal
sudv
vlp
mix
freund
adjuv
could
stimul
hors
produc
humor
immun
respons
regard
research
sudv
therapeut
antibodi
select
hors
serum
studi
serum
extract
purifi
obtain
purifi
igg
hors
serum
purifi
igg
simultan
subject
viru
neutral
find
show
neutral
antibodi
titer
hors
serum
fifth
immun
correspondingli
neutral
antibodi
titer
purifi
igg
figur
mechan
natur
immun
ebov
remain
unclear
efficaci
differ
type
vaccin
may
vari
depend
vaccin
platform
antibodi
major
immun
correl
factor
rvsvzebov
vaccin
meanwhil
cell
respons
attribut
protect
vaccin
previou
vlp
vaccin
studi
show
efficaci
lethal
ebola
challeng
howev
differ
adjuv
save
antigen
enhanc
vaccineinduc
immun
respons
impact
sudv
outbreak
recent
year
potenti
viral
spread
nonendem
region
countri
make
develop
safe
efficaci
vaccin
urgent
previou
find
reveal
sudv
vlp
could
readili
assembl
coexpress
baculovirus
express
gp
np
insect
cell
demonstr
coinfect
rbvgpgp
recombin
baculovirus
result
success
assembl
vlp
insect
cell
morpholog
sudv
vlp
similar
nativ
viru
immunogen
vlp
test
isa
adjuv
candid
vaccin
mice
studi
gener
recombin
baculavirus
rbvgpgp
use
pfastbacdu
vector
increas
protein
product
util
dual
promot
determin
optim
proport
two
recombin
baculavirus
rbvgpgp
also
tri
coinfect
cell
recombin
baculavirus
rbvgpgp
ratio
ratio
morpholog
vlp
similar
nativ
viru
assess
tem
figur
western
blot
result
figur
show
sudv
gp
effici
assembl
sudv
vlp
immun
result
depict
failur
group
vaccin
sudv
vlpsonli
stimul
product
humor
immun
respons
mice
group
vaccin
vlp
mix
isa
adjuv
could
stimul
product
humor
immun
mice
presum
immun
sudv
vlpsonli
insuffici
low
dose
immunogen
stimul
mice
produc
immun
respons
use
isa
adjuv
sudv
vlp
might
caus
lowdos
immunogen
initi
respons
use
adjuv
save
antigen
amount
figur
sudv
vlp
antigen
dose
mix
differ
adjuv
could
stimul
mice
produc
differ
degre
humor
immun
respons
isa
adjuv
show
effect
adjuv
adjuv
mice
detect
neutral
antibodi
show
sera
mice
immun
sudv
vlp
mix
isa
adjuv
could
neutral
approxim
pseudotyp
virus
averag
dilut
individu
sampl
effect
high
dilut
figur
humor
cellular
respons
indispens
provid
protect
cytokin
involv
antivir
action
cellular
immun
respons
mainli
produc
cell
associ
humor
immun
respons
sudv
vlp
could
effect
stimul
cytokin
product
vaccin
mice
figur
b
level
cytokin
secret
splenocyt
secret
cell
figur
c
secret
cell
figur
e
significantli
increas
vaccin
moreov
studi
reveal
b
cell
mice
group
vaccin
sudv
vlp
mix
isa
adjuv
activ
one
week
primari
immun
figur
addit
conduct
research
therapeut
antibodi
goal
prepar
antibodi
postexposur
treatment
sudv
hors
select
immun
anim
studi
hors
antiimmunoglobulin
use
treatment
variou
viral
infect
sudv
vlp
effect
induc
humor
immun
respons
hors
immun
figur
hors
antisudv
immunoglobulin
obtain
hors
serum
crude
extract
purif
neutral
antibodi
titer
purifi
igg
one
time
lower
purif
figur
test
sudv
vlp
immunogen
neutral
activ
hour
purifi
igg
use
pseudo
type
virus
efficaci
studi
still
need
perform
sudv
vlp
vaccin
hors
purifi
igg
provid
idea
develop
vaccin
therapeut
antibodi
could
prevent
treat
sudv
infect
ebola
epidem
still
spread
vaccin
effect
mean
prevent
control
outbreak
effect
antibodi
repres
key
drug
treatment
ebola
patient
therefor
ebola
vaccin
therapeut
antibodi
research
need
author
declar
conflict
interest
